-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO SHARES DOWN 20% AFTER FDA ISSUES WARNING LETTER OVER "FALSE OR MISLEADING" ANKTIVA CLAIMS

Reuters·03/24/2026 14:31:49

Please log in to view news